马来西亚市场个股详情

PHARMA (7081)

添加自选
  • 0.245
  • -0.005-2.00%
延时15分钟行情未开盘 04/24 16:59 (北京)
16.06亿总市值18.85市盈率TTM

7081 PHARMA

季报+年报
显示同比 yoy
隐藏空行 yoy
(FY)2025/12/31
(Q4)2025/12/31
(Q3)2025/09/30
(Q2)2025/06/30
(Q1)2025/03/31
(FY)2024/12/31
(Q4)2024/12/31
(Q3)2024/09/30
(Q2)2024/06/30
(Q1)2024/03/31
营业总收入
4.48%39.28亿
1.28%9.38亿
-2.19%10.07亿
10.57%9.27亿
9.37%10.55亿
10.43%37.59亿
17.30%9.26亿
16.30%10.3亿
-1.23%8.38亿
9.60%9.65亿
主营业务成本
9.31%35.19亿
2.56%8.41亿
13.66%9.12亿
10.85%8.37亿
10.35%9.29亿
3.95%32.19亿
4.71%8.2亿
3.50%8.02亿
0.39%7.55亿
7.04%8.42亿
毛利
-24.30%4.09亿
-8.63%9,699.5万
-58.10%9,529.9万
8.00%9,025.3万
2.68%1.27亿
75.59%5.4亿
1,553.96%1.06亿
106.29%2.27亿
-13.82%8,356.5万
30.95%1.23亿
营业费用
-0.02%2.79亿
-3.04%7,367.4万
1.96%7,316.9万
3.97%6,651.7万
-2.49%6,615.1万
-14.85%2.79亿
161.57%7,598.6万
-52.48%7,176万
-15.76%6,397.9万
-6.11%6,784.3万
销售、一般行政及管理费用
-0.02%2.8亿
----
----
----
----
-14.84%2.8亿
----
----
----
----
-一般及行政管理费用
-0.02%2.8亿
----
----
----
----
-14.84%2.8亿
----
----
----
----
其他营业费用
-0.02%2.8亿
-3.04%7,367.4万
1.96%7,316.9万
3.97%6,651.7万
-2.49%6,615.1万
-14.84%2.8亿
161.57%7,598.6万
-52.48%7,176万
-15.76%6,397.9万
-6.11%6,784.3万
其他营业收入总额
0.00%26万
----
----
----
----
-0.38%26万
----
----
----
----
营业利润
-50.26%1.3亿
-22.69%2,332.1万
-85.79%2,213万
21.19%2,373.6万
9.00%6,045.8万
1,393.96%2.61亿
233.28%3,016.5万
482.14%1.56亿
-6.85%1,958.6万
153.19%5,546.6万
营业外利息收入与支出净额
20.13%-5,568.6万
43.83%-996.4万
29.45%-1,225.5万
4.93%-1,680.2万
1.58%-1,666.5万
-15.49%-6,971.7万
-11.13%-1,773.9万
-9.60%-1,737.1万
-16.02%-1,767.4万
-27.13%-1,693.3万
营业外利息收入
151.29%565.9万
459.14%220.3万
169.37%239.2万
-15.38%44万
38.67%62.4万
52.47%225.2万
27.10%39.4万
148.04%88.8万
256.16%52万
-32.13%45万
营业外利息支出
-14.76%6,134.5万
-32.90%1,216.7万
-19.78%1,464.7万
-5.23%1,724.2万
-0.54%1,728.9万
16.37%7,196.9万
11.43%1,813.3万
12.65%1,825.9万
18.30%1,819.4万
24.32%1,738.3万
投资净收益
被指定为现金流套期的金融工具损益
终止确认可供出售金融资产损益
联营企业及其他参股权益产生的收益
特殊收入(费用)
237.97%26.7万
-90.86%7.9万
减:其他特殊费用
-237.97%-26.7万
----
----
----
----
90.86%-7.9万
----
----
----
----
减:勾销
--0
----
----
----
----
--0
----
----
----
----
其他营业外收入(费用)
-90.46%25.1万
-314.81%-191.4万
227.89%48.2万
-64.84%50万
234.64%171万
562.97%263.2万
-22.92%89.1万
-56.51%14.7万
158.55%142.2万
-15.54%51.1万
税前利润
-61.51%7,473.7万
-14.07%1,144.3万
-92.52%1,035.7万
122.98%743.4万
16.54%4,550.3万
348.43%1.94亿
135.57%1,331.7万
346.16%1.38亿
-47.43%333.4万
324.71%3,904.4万
所得税
-60.17%2,405.3万
-75.05%271.1万
-92.29%286.6万
729.10%322.1万
18.58%1,525.5万
10,293.46%6,038.6万
509.77%1,086.7万
615.34%3,716.6万
-112.74%-51.2万
100.17%1,286.5万
除税后利润
-62.12%5,068.4万
256.41%873.2万
-92.61%749.1万
9.54%421.3万
15.54%3,024.8万
269.91%1.34亿
107.04%245万
306.58%1.01亿
65.49%384.6万
846.46%2,617.9万
持续经营利润
-62.12%5,068.4万
256.41%873.2万
-92.61%749.1万
9.54%421.3万
15.54%3,024.8万
269.91%1.34亿
107.04%245万
306.58%1.01亿
65.49%384.6万
846.46%2,617.9万
归属于少数股东的净利润
10.24%217.4万
906.80%103.7万
-25.09%21.5万
-75.88%25.3万
25.52%66.9万
39.27%197.2万
-83.96%10.3万
-1.71%28.7万
188.98%104.9万
351.69%53.3万
归属于母公司的净利润
-63.20%4,851万
227.87%769.5万
-92.80%727.6万
41.58%396万
15.34%2,957.9万
264.45%1.32亿
106.62%234.7万
304.77%1.01亿
42.63%279.7万
868.50%2,564.6万
优先股派息
其他优先股派息
0
0
0
0
0
0
0
0
0
0
归属于普通股股东的净利润
-63.20%4,851万
227.87%769.5万
-92.80%727.6万
41.58%396万
15.34%2,957.9万
264.45%1.32亿
106.62%234.7万
304.77%1.01亿
42.63%279.7万
868.50%2,564.6万
总派息金额
基本每股收益
-75.37%0.0134
120.82%0.0021
-93.28%0.0028
42.04%0.0016
15.17%0.0122
256.14%0.0544
106.18%0.001
291.01%0.0417
26.68%0.0011
789.99%0.0106
稀释每股收益
-75.37%0.0134
120.82%0.0021
-93.28%0.0028
42.04%0.0016
15.17%0.0122
256.14%0.0544
106.18%0.001
291.01%0.0417
26.68%0.0011
789.99%0.0106
每股派息
0
0
0
0
0
0
0
0
0
0
会计准则
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)2025/12/31(Q4)2025/12/31(Q3)2025/09/30(Q2)2025/06/30(Q1)2025/03/31(FY)2024/12/31(Q4)2024/12/31(Q3)2024/09/30(Q2)2024/06/30(Q1)2024/03/31
营业总收入 4.48%39.28亿1.28%9.38亿-2.19%10.07亿10.57%9.27亿9.37%10.55亿10.43%37.59亿17.30%9.26亿16.30%10.3亿-1.23%8.38亿9.60%9.65亿
主营业务成本 9.31%35.19亿2.56%8.41亿13.66%9.12亿10.85%8.37亿10.35%9.29亿3.95%32.19亿4.71%8.2亿3.50%8.02亿0.39%7.55亿7.04%8.42亿
毛利 -24.30%4.09亿-8.63%9,699.5万-58.10%9,529.9万8.00%9,025.3万2.68%1.27亿75.59%5.4亿1,553.96%1.06亿106.29%2.27亿-13.82%8,356.5万30.95%1.23亿
营业费用 -0.02%2.79亿-3.04%7,367.4万1.96%7,316.9万3.97%6,651.7万-2.49%6,615.1万-14.85%2.79亿161.57%7,598.6万-52.48%7,176万-15.76%6,397.9万-6.11%6,784.3万
销售、一般行政及管理费用 -0.02%2.8亿-----------------14.84%2.8亿----------------
-一般及行政管理费用 -0.02%2.8亿-----------------14.84%2.8亿----------------
其他营业费用 -0.02%2.8亿-3.04%7,367.4万1.96%7,316.9万3.97%6,651.7万-2.49%6,615.1万-14.84%2.8亿161.57%7,598.6万-52.48%7,176万-15.76%6,397.9万-6.11%6,784.3万
其他营业收入总额 0.00%26万-----------------0.38%26万----------------
营业利润 -50.26%1.3亿-22.69%2,332.1万-85.79%2,213万21.19%2,373.6万9.00%6,045.8万1,393.96%2.61亿233.28%3,016.5万482.14%1.56亿-6.85%1,958.6万153.19%5,546.6万
营业外利息收入与支出净额 20.13%-5,568.6万43.83%-996.4万29.45%-1,225.5万4.93%-1,680.2万1.58%-1,666.5万-15.49%-6,971.7万-11.13%-1,773.9万-9.60%-1,737.1万-16.02%-1,767.4万-27.13%-1,693.3万
营业外利息收入 151.29%565.9万459.14%220.3万169.37%239.2万-15.38%44万38.67%62.4万52.47%225.2万27.10%39.4万148.04%88.8万256.16%52万-32.13%45万
营业外利息支出 -14.76%6,134.5万-32.90%1,216.7万-19.78%1,464.7万-5.23%1,724.2万-0.54%1,728.9万16.37%7,196.9万11.43%1,813.3万12.65%1,825.9万18.30%1,819.4万24.32%1,738.3万
投资净收益
被指定为现金流套期的金融工具损益
终止确认可供出售金融资产损益
联营企业及其他参股权益产生的收益
特殊收入(费用) 237.97%26.7万-90.86%7.9万
减:其他特殊费用 -237.97%-26.7万----------------90.86%-7.9万----------------
减:勾销 --0------------------0----------------
其他营业外收入(费用) -90.46%25.1万-314.81%-191.4万227.89%48.2万-64.84%50万234.64%171万562.97%263.2万-22.92%89.1万-56.51%14.7万158.55%142.2万-15.54%51.1万
税前利润 -61.51%7,473.7万-14.07%1,144.3万-92.52%1,035.7万122.98%743.4万16.54%4,550.3万348.43%1.94亿135.57%1,331.7万346.16%1.38亿-47.43%333.4万324.71%3,904.4万
所得税 -60.17%2,405.3万-75.05%271.1万-92.29%286.6万729.10%322.1万18.58%1,525.5万10,293.46%6,038.6万509.77%1,086.7万615.34%3,716.6万-112.74%-51.2万100.17%1,286.5万
除税后利润 -62.12%5,068.4万256.41%873.2万-92.61%749.1万9.54%421.3万15.54%3,024.8万269.91%1.34亿107.04%245万306.58%1.01亿65.49%384.6万846.46%2,617.9万
持续经营利润 -62.12%5,068.4万256.41%873.2万-92.61%749.1万9.54%421.3万15.54%3,024.8万269.91%1.34亿107.04%245万306.58%1.01亿65.49%384.6万846.46%2,617.9万
归属于少数股东的净利润 10.24%217.4万906.80%103.7万-25.09%21.5万-75.88%25.3万25.52%66.9万39.27%197.2万-83.96%10.3万-1.71%28.7万188.98%104.9万351.69%53.3万
归属于母公司的净利润 -63.20%4,851万227.87%769.5万-92.80%727.6万41.58%396万15.34%2,957.9万264.45%1.32亿106.62%234.7万304.77%1.01亿42.63%279.7万868.50%2,564.6万
优先股派息
其他优先股派息 0000000000
归属于普通股股东的净利润 -63.20%4,851万227.87%769.5万-92.80%727.6万41.58%396万15.34%2,957.9万264.45%1.32亿106.62%234.7万304.77%1.01亿42.63%279.7万868.50%2,564.6万
总派息金额
基本每股收益 -75.37%0.0134120.82%0.0021-93.28%0.002842.04%0.001615.17%0.0122256.14%0.0544106.18%0.001291.01%0.041726.68%0.0011789.99%0.0106
稀释每股收益 -75.37%0.0134120.82%0.0021-93.28%0.002842.04%0.001615.17%0.0122256.14%0.0544106.18%0.001291.01%0.041726.68%0.0011789.99%0.0106
每股派息 0000000000
会计准则 NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

FY:Financial Year 年度报告,相当于上市公司向SEC披露的10-K文件。

Q:Quarter 季度报告,相当于上市公司向SEC披露的10-Q文件,其中Q1、Q2、Q3、Q4为单季报,跨度为3个月;Q6、Q9为累计季报,Q6为6个月,Q9为9个月。

热门市场机会
中东战火燃至股市!投资者该如何应对?
美伊第二轮谈判现重启迹象,据报道,伊朗外长已于周五抵达巴基斯坦,将与巴方讨论美伊谈判的先决条件,包括解除封锁和解冻资产等;巴方预计会谈将促成美伊第二轮对话;特朗普将派威特科夫和库什纳参加会谈,若会谈取得进展,万斯随时待命前往。 市场同时聚焦关键时间窗口:5月1日为美国《战争权力法 展开